paclitaxel has been researched along with Intestinal Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, T; Hida, K; Horimatsu, T; Hoshino, N; Muto, M; Nakayama, T; Nishikawa, Y; Sakai, Y | 1 |
| Aldrich, JD; Overman, MJ; Raghav, KPS; Varadhachary, GR; Wolff, RA | 1 |
| Čáňová, K; Hanušová, V; Knoppová, K; Králová, V; Skálová, L; Staňková, P | 1 |
| Arai, T; Komatsu, Y; Munakata, M; Saitoh, H; Saitoh, S; Sakata, Y; Sato, T; Shimamura, T; Takagane, A; Yamaguchi, K; Yoshioka, T | 1 |
| Aihara, R; Asao, T; Haga, N; Kamiyama, Y; Kuwano, H; Mochiki, E; Nakabayashi, T; Nakamura, J; Ohno, T; Ohsawa, H; Ojima, H; Takeuchi, K | 1 |
1 review(s) available for paclitaxel and Intestinal Neoplasms
| Article | Year |
|---|---|
Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.
Topics: Adenocarcinoma; Albumins; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; Intestinal Neoplasms; Intestine, Small; Paclitaxel; Prospective Studies; Treatment Outcome | 2020 |
2 trial(s) available for paclitaxel and Intestinal Neoplasms
| Article | Year |
|---|---|
Phase I-II study of biweekly paclitaxel administration with fixed-dose-rate cisplatin in advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Intestinal Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Paclitaxel; Stomach Neoplasms; Survival Rate | 2006 |
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Combinations; Female; Humans; Intestinal Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome | 2006 |
2 other study(ies) available for paclitaxel and Intestinal Neoplasms
| Article | Year |
|---|---|
Retrospective Analysis of Taxane-Based Therapy in Small Bowel Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate | 2019 |
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
Topics: Adenocarcinoma; Albendazole; Anthelmintics; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; G2 Phase; Humans; Inhibitory Concentration 50; Intestinal Neoplasms; Mebendazole; Microtubules; Paclitaxel; Protein Stability; Tubulin Modulators | 2013 |